Inji Chooranam as Internal Medicine and Aayil Ennai as External Therapy for Sirakambhavatham (Cerebral Palsy)

Phase II Clinical Study In The Management Of Sirakambhavatham (Cerebral Palsy) With The Evaluation Of Siddha Trial Drug Inji Chooranam (Internal Medicine) And Aayil Ennai (External Therapy) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108110

Enrollment

Registered

2026-04-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G800- Spastic quadriplegic cerebral palsy

Interventions

Intervention1: INJI CHOORANAM (INTERNAL) AAYIL ENNAI ( EXTERNAL): Inji chooranam is given as internal medicine. Dose is fixed according to the pediatric age and BMI,BDS with Ghee, after food for 48 d

Eligibility

Inclusion criteria

Inclusion criteria: Both male and female children. Delay in milestones. Delay in intellectual and cognitive functional development. Abnormal muscle tone and reflexes. Spastic cerebral palsy.

Exclusion criteria

Exclusion criteria: Children above 12 years. Patient with severe seizure disorder. Patients with severe serious illnesses. Autism spectrum disorders. Mixed type of cerebral palsy. Ataxic/Dyskinetic/Athetoid/Choreoathetoid/Dystonic.

Design outcomes

Primary

Measure	Time frame
The prognosis will be given on the basis of evaluation of sensory functions connecting parameters such as visual, hearing and vocal in GMFCS, language, cognitive, socioemotional and behavior skills and improvement in motor parameter such as spasticity, muscle tone, GMFCS, gait, stiffness in the joints and fine motor functions of the upper limb. This study will help to understand the effects of Inji chooranam and as internal medicine and Aayil ennaias external therapy in management of Sirakambavatham in children.Timepoint: 48 days	—

Measure

Time frame

The prognosis will be given on the basis of evaluation of sensory functions connecting parameters such as visual, hearing and vocal in GMFCS, language, cognitive, socioemotional and behavior skills and improvement in motor parameter such as spasticity, muscle tone, GMFCS, gait, stiffness in the joints and fine motor functions of the upper limb. This study will help to understand the effects of Inji chooranam and as internal medicine and Aayil ennaias external therapy in management of Sirakambavatham in children.Timepoint: 48 days

—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr C Shanmugapriya

Government Siddha Medical College, Arumbakkam, Chennai.

cspriya1974@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026